WHAT DOES IT MEAN THAT WE DO CLINICAL TRIALS?
New therapies, including medications, medical devices and surgical procedures, are evaluated in research studies known as clinical trials. Often these new therapies are investigational, which means they are not yet approved by the U.S. Food and Drug Administration for general use. However, clinical trials are done under the supervision of the FDA.
Participation in clinical trials offers the potential for new treatment options and allows patients to participate with researchers in driving the discovery of effective therapies. There are always risks involved, some known and possibly some that are unknown, and patients should consult with their physicians in considering the appropriateness of a clinical trial for their particular situation.
WHY CHOOSE US?
We have LOTS of experience (we've been doing this for almost 20 years)
We are involved in many clinical areas
Neuroscience lags just behind Cancer as to the most heavily invested in and funded area for clinical trials, spanning cutting edge treatments in Migraine, Chronic pain, Epilepsy, Multiple Sclerosis, ALS (Lou Gerhig's Disease), all types of Chronic Pain Treatment incluing Neuropathy and Post Herpetic Neurology, Parkinson's and other Movement Disorders, Dementia such as Alzheimer's and many many more!
We are committed to the South Shore - we live out her and we understand Manhattan offers some of the best medical care and research in the world, yet we stand inspired and challenged to offer that same level of care and research right here on Long Island's South Shore giving local patient's access to cutting edge treatment options
We view our efforts as giving back to the community - many of us enjoyed and miss the rigors of our academic training and while we practice clinical medicine working in clinical trials research helps us synthesize our basic science and fundamental knowledge to helping our patients get the latest and greatest treatment out there
CURRENT CLINICAL TRIALS
We are currently involved in a study that evaluates the safety & efficacy of an investigational product for agitation associated with Alzheimer’s disease.
MULTIPLE SCLEROSIS (MS)
We are currently conducting clinical research trials for patients with a diagnosis of relapsing remitting Multiple Sclerosis.
We are working on a number of trials now enrolling for drug-resistant epilepsy.